Ann: Appendix 4C - quarterly, page-116

I’m still here (averaged up without selling) and you are right about ‘ .... should not be playing in this game’, flip side is this though, without us ‘‘unsophisticated’ investors, present and former, there would most likely be no Admedus.

Disappointed, heck yes, worried.... you betcha, one more missed forecast and you know what may be on the cards, it will be a killing field.

I am puzzled how the company can ‘predict’ when tga approvals will be given, surely it is a fact that they come when they come (often later than hoped for) and then ‘bank’ on it. If not in the next few weeks than will the next forecast be downgraded.

From here on in perhaps they need to do a monthly update on how the their forecasts are travelling, that would be true transparency, though unlikely to happen, it is catch up time now.

Optimistic tweets etc, I guess to be taken with a handful of salt these days, lol, solution; save them for when forecasts are met and share appreciation is evident.